Skip to content

ACtive Care After Transplantation, the ACT Study

ACtive Care After Transplantation, a Lifestyle Intervention in Renal Transplant Recipients

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01047410
Acronym
ACT
Enrollment
221
Registered
2010-01-12
Start date
2010-10-31
Completion date
2017-11-01
Last updated
2018-08-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Kidney Transplant, Metabolic Syndrome, Post-transplant Weight Gain

Keywords

physical exercise training, quality of life, exercise capacity, skeletal muscle strength, physical activity level, costeffectiveness, renal transplantation, hemodialysis, peritoneal dialysis, diet

Brief summary

The aim of the present study is to compare the outcomes of standard care to the effects of exercise alone, and exercise combined with nutrition counseling, on post-transplantation weight gain and quality of life in renal transplant recipients (RTR). The primary outcome is subdomain physical functioning of quality of life, (SF-36 PFS). Secondary outcomes include other evaluations of quality of life (SF-36, KDQOL-SF, EQ-5D), objective measures of physical functioning (aerobic capacity and muscle strength), level of physical activity, gain in adiposity (body fat percentage by bio-electrical impedance assessment, BMI, waist circumference), and cardiometabolic risk factors (blood pressure, lipids, glucose metabolism). Additionally it is planned to study data on renal function, medical history, medication, psychological factors (motivation, kinesiophobia, coping style), nutrition knowledge, nutrition intake, nutrition status, fatigue, work participation, process evaluation and cost-effectiveness.

Detailed description

Patient and graft survival in the first year after renal transplantation have improved substantially over the last decade, but long-term graft loss and patient mortality have remained high. It is increasingly recognized that the alarmingly poor cardio-metabolic risk profile in renal transplant recipients (RTR) plays a main role in long-term outcome. Improvement of long-term outcome will require specific efforts to improve cardio-metabolic profile and its complications. Importantly, the substantial increase in body weight and body fat that occurs after transplantation is a major trigger for the poor cardiometabolic profile in the RTR, including post-transplant diabetes and metabolic syndrome. The increase in body weight is mostly fat tissue and typically around 9-10 kg. Most of this weight gain (\ 90%) occurs in the first year after transplantation. Recent data indicate that steroid avoidance could not prevent this early increase in adiposity. This warrants specific focus on lifestyle factors, i.e diet and physical activity. In the UMCG RTR cohort we found that a lack of physical activity was related to a worse cardiometabolic profile and was an independent predictor of mortality. Moreover, the substantial increase in fat massweight gain was strongly related to low physical activity, high intake of energy-dense drinks, low consumption of vegetables, to increased plasma triglycerides and the metabolic syndrome. The intake of salt and saturated fat was high and fibre intake was low, indicating dietary habits that deviate substantially from recommendations for a healthy diet. Thus, both physical activity and dietary habits are important targets for lifestyle intervention in RTR. Lasting improvements in lifestyle are notoriously difficult to obtain, but in recent years substantial intervention expertise has been developed in other high risk groups including prediabetes. It is now established that for long term purposes, prevention of excessive weight gain is more effective than treatment of weight excess. Since in RTR most of the weight is gained in the first year after transplantation, prevention is a very promising approach. Moreover, data in prediabetes suggest that combined intervention targeting both diet and physical activity may be particularly effective to this purpose. Therefore, our aim is to investigate the effects on quality of life by a combined diet-and-physical activity program in RTR in the first year after transplantation. This randomized controlled intervention study will use a combined diet-and-physical activity approach. After hospital discharge for transplantation, 219 patients will be randomized to three either a control groups: one group, who will receive standard care, one group will be exposed to a 3-month exercise program followed by individual counselling and one group will be exposed to the exercise program + dietary or to intervention followed by individual counselling. The individual counselling is to consolidate the achieved improvements in diet and physical activity and will be provided until 15 months after inclusion. This counselling is based on theories of behavioural change and motivational interviewing. Daily physical activity is evaluated with a pedometer and dietary habits by questionnaires and food records.

Interventions

OTHERExercise intervention

Patients assigned to the exercise intervention participate in a 12 weeks lasting, intensive, standardized and supervised physical training program which consists of a combination of endurance and strength training. After completion of the training program, patients receive an individual sport- and physical activity advice and lifestyle coaching.

OTHERExercise intervention and dietary advice

The exercise intervention in this group is identical to the exercise-only group. The nutritional intervention runs throughout the entire 15 month intervention. The nutritional intervention aims to critically discuss pre-transplantation nutritional habits, and to set goals for healthier, better quality nutrition to prevent over eating and weight gain. These goals are set together with the subject to facilitate an autonomy supportive coaching climate.During the dietary consults, special attention goes out to saturated fat intake, whole-wheat and high fibre foods, fruit and vegetable intake, dietary salt consumption, and the use of energy-rich beverages such as soda, dairy drinks and fruit juices.

Sponsors

Dutch Kidney Foundation
CollaboratorOTHER
Innovation Fund of the Dutch Medical Insurance Companies
CollaboratorUNKNOWN
University Medical Center Groningen
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Masking description

Outcomes assessors are blinded if possible.

Intervention model description

3-arm randomized controlled trial

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age ≥ 18 years; * Informed Consent; * \>1 year after transplantation * Medical approvement for participation in the study by the nephrologist.

Exclusion criteria

* Psychopathology; * Severe cognitive disorders; * Negative advice of the nephrologist and/or cardiologist.

Design outcomes

Primary

MeasureTime frameDescription
Quality of life - Physical Functioning Scorebaseline, 12 weeks, 6 months and 15 monthsThe subdomain 'Physical Functioning' of Quality of Life (SF36 questionnaire)

Secondary

MeasureTime frameDescription
Cardiometabolic risk factorsbaseline, 12 weeks, 6 months and 15 monthsBlood pressure
Quality of Life Scoresbaseline, 12 weeks, 6 months and 15 monthsPhysical and Mental scores of the Quality of Life SF36 questionnaire
Physical functioningbaseline, 12 weeks, 6 months and 15 monthsExercise capacity by VO2max test and/or submax test
Body compositionbaseline, 12 weeks, 6 months and 15 monthswaist circumference
nutritionbaseline, 12 weeks, (6 months for nutrition intervention only) and 15 monthsdietary intake (food diaries)
Chronic fatiguebaseline, 12 weeks, 6 months and 15 monthsCIS-20 questionnaire
Fatigue and work participationbaseline, 12 weeks, 6 months and 15 monthsFatigue and work questionnaire (NFR)
Cost-effectivenessbaseline, 12 weeks, 6, 9, 12 and 15 monthscare consumption and intervention costs
Psychological factors12 weeks and 15 monthsmotivation (questionnaire)

Countries

Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 26, 2026